IP Library Granted Patent US 8,691,953
Granted Patent B2
US 8,691,953 · App. 13/330,902 · Granted Apr 8, 2014

Binding compounds for IL-27

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,691,953
App. No.
13/330,902
Granted
Apr 8, 2014
Kind
B2
Abstract

Purified genes encoding a cytokine or composite cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding these molecules are provided. Methods of using said reagents and diagnostic kits are also provided.

Claims (8)

1. An isolated antibody, or antigen-binding fragment thereof, that specifically binds to a polypeptide consisting of the mature amino acid sequence of SEQ ID NO: 6.

2. The isolated antibody or antigen-binding fragment of claim 1 , wherein the antibody is a monoclonal antibody.

3. The isolated antibody or antigen-binding fragment of claim 2 , wherein the antibody is a chimeric antibody.

4. The isolated antibody or antigen-binding fragment of claim 2 , wherein the antibody is a humanized antibody.

5. The isolated antibody or antigen-binding fragment of claim 1 , wherein the antibody or fragment is an Fab or F(ab′) 2 antibody fragment.

6. A kit comprising the antibody or fragment of claim 1 , and a compartment, wherein said antibody or fragment is contained within said compartment.

7. The kit of claim 6 wherein the antibody or fragment is detectably labeled.

8. The kit of claim 7 wherein the antibody or fragment is labeled with an enzyme, a fluorescent label, a radioisotope or biotin.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →